{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T11:59:49Z","timestamp":1764935989629,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.htct.2021.06.003","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T21:26:37Z","timestamp":1627593997000},"page":"77-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incidence and clinical significance of FLT3 and nucleophosmin mutation in childhood acute myeloid leukemia in Chile"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9059-3871","authenticated-orcid":false,"given":"Maria Elena","family":"Cabrera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Monardes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Cares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2646-0980","authenticated-orcid":false,"given":"Claudio","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2021.06.003_bib0001","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Steven","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.htct.2021.06.003_bib0002","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1200\/JCO.2009.24.8997","article-title":"Cytogenetics of childhood acute myeloid leukemia: united Kingdom Medical Research Council Treatment trials AML 10 and 12","volume":"28","author":"Harrison","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.htct.2021.06.003_bib0003","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1200\/JCO.2009.25.6321","article-title":"Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98","volume":"28","author":"von Neuhoff","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.htct.2021.06.003_bib0004","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MOP.0000000000000855","article-title":"Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy. Review","volume":"32","author":"Elgarten","year":"2020","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.htct.2021.06.003_bib0005","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1002\/cncr.30220","article-title":"Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups","volume":"122","author":"Creutzig","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.htct.2021.06.003_bib0006","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/sj.leu.2401241","article-title":"Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia: the Children's Cancer and Leukemia Study Group, Japan","volume":"13","author":"Iwai","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.htct.2021.06.003_bib0007","first-page":"190","article-title":"FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group","volume":"111","author":"Abu-Duhier","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.htct.2021.06.003_bib0008","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1182\/blood.V99.12.4326","article-title":"Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis","volume":"99","author":"Thiede","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.htct.2021.06.003_bib0009","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/sj.leu.2403790","article-title":"Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group","volume":"19","author":"Callens","year":"2005","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.htct.2021.06.003_bib0010","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/pbc.24122","article-title":"FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group","volume":"59","author":"Kutny","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.htct.2021.06.003_bib0011","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1182\/blood-2006-03-009233","article-title":"Clinical implications of FLT3 mutations in pediatric AML","volume":"108","author":"Meshinchi","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.htct.2021.06.003_bib0012","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2005-06-2248","article-title":"Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype","volume":"106","author":"Schnittger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.htct.2021.06.003_bib0013","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/hon.904","article-title":"Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity","volume":"27","author":"Rau","year":"2009","journal-title":"Hematol Oncol"},{"issue":"15","key":"10.1016\/j.htct.2021.06.003_bib0014","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1182\/blood-2014-04-570929","article-title":"NUP98\/NSD1 and FLT3\/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report","volume":"124","author":"Ostronoff","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.htct.2021.06.003_bib0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1078155218802620","article-title":"FLT3 inhibitors in acute myeloid leukemia: current and future","volume":"25","author":"Thomas","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.htct.2021.06.003_bib0016","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3389\/fped.2020.00586","article-title":"Profiling FLT3 mutations in Mexican acute myeloid leukemia pediatric patients: impact on overall survival","volume":"8","author":"Molina Garay","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.htct.2021.06.003_bib0017","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood-2005-03-0899","article-title":"Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype","volume":"106","author":"Cazzaniga","year":"2005","journal-title":"Blood"},{"year":"2013","series-title":"ISCN: An international system for human cytogenetic nomenclature","key":"10.1016\/j.htct.2021.06.003_bib0018"},{"key":"10.1016\/j.htct.2021.06.003_bib0019","unstructured":"Gu\u00edas Cl\u00ednicas AUGE Subsecretar\u00eda de Salud P\u00fablica Divisi\u00f3n de prevenci\u00f3n y Control de Enfermedades Departamento Manejo Integral del C\u00e1ncer y otros Tumores. Leucemia en menores de 15 a\u00f1os. Available from: https:\/\/www.minsal.cl"},{"key":"10.1016\/j.htct.2021.06.003_bib0020","unstructured":"Leucemia en personas de 15 a\u00f1os y m\u00e1s. Available from: http:\/\/www.bibliotecaminsal.cl\/"},{"issue":"8","key":"10.1016\/j.htct.2021.06.003_bib0021","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.arcmed.2016.11.015","article-title":"Molecular characterization of pediatric acute myeloid leukemia: results of a multicentric study in Brazil","volume":"47","author":"Andrade","year":"2016","journal-title":"Arch Med Res"},{"key":"10.1016\/j.htct.2021.06.003_bib0022","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.2147\/CMAR.S194523","article-title":"Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis","volume":"11","author":"Huang","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.htct.2021.06.003_bib0023","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.leukres.2010.01.001","article-title":"Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: a systematic review","volume":"34","author":"Beitinjaneh","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.htct.2021.06.003_bib0024","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s12185-016-2064-5","article-title":"NPM1, FLT3 and CEBPA mutations in pediatric patients with AML from Argentina: incidence and prognostic value","volume":"104","author":"Rubio","year":"2016","journal-title":"Int Journal Hematol"},{"issue":"10","key":"10.1016\/j.htct.2021.06.003_bib0025","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/ajh.25214","article-title":"Acute myeloid leukemia: 2019 update on risk-stratification and management","volume":"93","author":"Estey","year":"2018","journal-title":"Am J Hematol"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137921000973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137921000973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:35:59Z","timestamp":1762868159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137921000973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2531137921000973"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2021.06.003","relation":{},"ISSN":["2531-1379"],"issn-type":[{"type":"print","value":"2531-1379"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and clinical significance of FLT3 and nucleophosmin mutation in childhood acute myeloid leukemia in Chile","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2021.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}